45 new SKUs launched this year sounds great in the commercial review — until you look at how many are real innovation, and how many are packaging variants dressed up as new. Here's the real formula, the three variants that actually matter, and the four root causes that quietly inflate the number.
(NPD revenue / Total revenue) x 100One row per billing document line — customer × product × plant × date
NPD_Revenue = NSV from products launched within the last 24 months, measured at current period actuals; Total_Net_Revenue = total NSV for the business in the period.
reformulations of existing products (unless repositioned with new code); range extensions that are pack size variants only.
new product revenue share in grocery decays faster than in any other channel — 70% of NPDs fail to survive year 2; a share figure that looks healthy is often supported by a single large launch that inflates the cohort; cohort-level revenue tracking by launch year is more actionable than aggregate NPD share.
Numerator is segmented by the year of launch (e.g., Y-1, Y-2). When to use it: To assess the 'stickiness' of innovation. A high overall share driven only by the most recent 6 months of launches indicates a 'leaky bucket' portfolio where new products fail to establish a baseline.
Measures the gross margin dollars from NPDs as a % of total company gross margin. When to use it: To expose 'hollow innovation' where new products generate revenue but are margin-dilutive due to high launch costs, inefficient production, or heavy trade spend. This is the CFO's preferred view.
Numerator is NPD revenue minus the estimated revenue lost from existing products due to cannibalization. When to use it: For a true measure of incremental growth. A high NPD share that simply replaces sales from a profitable core product is not a win. Requires marketing mix modeling or a similar analytical approach.
Weak 'New Product' Definition in Master Data. When the ERP or PLM system lacks a strict, mandatory field to classify innovation type (e.g., New Platform, Line Extension, Pack Change), commercial teams can flag minor changes as 'new', artificially inflating the KPI.
In the Material Master (SAP MM), pull all SKUs created in the last 24 months. Manually audit the list. If more than 30% are identifiable as simple pack size or flavour variants of existing products, the definition is too loose.
'We launched 45 new SKUs this year' in the commercial monthly report — this looks green because it measures activity, not the commercial or technical substance of the innovation.
Stage-Gate Process Lacks an 'Operational Readiness' Gate. The commercial team pushes a product through the gates based on market research and customer commitment, without a mandatory sign-off from Operations confirming it can be made at target cost, speed, and yield.
Review the Stage-Gate project documentation for the last five NPDs. If there is no gate with 'Manufacturing Trial Success at
'Project Phoenix is approved for launch' on the gate-keeping meeting minutes — this looks green because it passed the commercial hurdles, but ignores the uncosted operational chaos it will create.
Sales Incentives Based on 'Sell-In' Volume, Not 'Sell-Out' Velocity or Margin. When the sales team is bonused on the value of the initial orders from retailers, they are motivated to secure any listing, regardless of the product's actual consumer appeal or profitability.
Review the sales team's variable compensation plan. If the primary performance metric for NPDs is 'Initial Order Value' or 'New Distribution Points', the incentive is misaligned. Cross-reference with sell-out data (e.g., Nielsen/IRI) for the same products.
'NPD Volume Target Achieved at 105%' in the sales performance dashboard — this looks green because it measures the success of the negotiation with the retailer, not the success of the product with the shopper.
No Post-Launch P&L Tracking by NPD. Once a product is launched, its costs (manufacturing, logistics, trade spend) are pooled with the base business, making it impossible to isolate its true profitability. There is no formal process to kill value-destructive 'zombie' innovations.
Ask the Finance team to produce a P&L for a specific product launched 12 months ago. If they cannot do it within 48 hours without a major data-pulling exercise, the capability does not exist.
'The category is up 5% in revenue' in the monthly finance pack — this looks green because the aggregate number hides the fact that a new, low-margin product is dragging down the overall profitability of the mix.
Mandate 'Innovation Type' in Master Data. SKU creation process allows ambiguous 'new' products → Add a mandatory, locked-down 'Innovation Type' field (e.g., New Platform, Line Extension, Pack Change, Relaunch) to the SKU creation workflow in SAP MM → NPD Revenue Share report can be filtered for 'true innovation', improving accuracy within one cycle.
Launch a 'Zombie SKU' Deletion Process. Unprofitable NPDs remain in the portfolio indefinitely → Run a quarterly report flagging all SKUs aged 12-24 months that are below a gross margin threshold and have declining sales velocity → Formal S&OP decision to either fix the margin or delist the SKU, freeing up working capital.
Introduce an 'Operational Readiness' Gate Review. Products are approved for launch without proven manufacturing capability → Insert a hard gate in the Stage-Gate process requiring sign-off from Operations on achieving target yield and efficiency in a full-scale trial run → Prevents commercially 'ready' but operationally unviable products from launching.